期刊
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
卷 14, 期 1, 页码 868-880出版社
AMER SCIENTIFIC PUBLISHERS
DOI: 10.1166/jnn.2014.9122
关键词
Lymphatic Delivery; Nano-Sized Carriers; Anti-Cancer Agents; Immunotherapeutic Agents; Lymphoid Contrast Agents
类别
资金
- National Research Foundation of Korea (NRF)
- Korean government (MEST) [2011-0029209]
- National Research Foundation of Korea [2011-0029209] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
The lymphatic system plays important roles for immune responses, spreading cancer cells or viruses and disseminating infections. Thus, targeting drugs, such as anticancer, immunotherapeutic and lymphoid contrast agents, to both tumors and the lymphatics, has several advantages such as reduced systemic side effects and increased efficacy. For these reasons, much interest has been focused on the nature of the lymphatics and various studies on the lymphatic delivery of drugs have been carried out. Because the lymphatics consist of a single layer endothelium and have higher permeability compared with that of blood capillaries, studies using nano-sized carriers have been performed. Polymeric nanoparticles, liposomes, and lipid-based vehicles have been adopted as lymphatic delivery carriers. This review will focus on the clinical use of such nano-sized carriers that have been developed for imaging and drug delivery to the lymphatic system. Lymphatic delivery of drugs, such as anticancer, immunotherapeutic and lymphoid contrast agents, using nano-sized carriers has much more improved ability compared with that of conventional dosage forms, but it has not shown the specific lymphatic targeting ability yet. Finally, the challenges for the future are suggested in terms of the mechanisms governing the lymphatic delivery of nano-sized carriers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据